Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma (AIMM)

This study has been withdrawn prior to enrollment.
(Study stopped due to low enrolment rate.)
Sponsor:
Information provided by (Responsible Party):
Onxeo
ClinicalTrials.gov Identifier:
NCT01764009
First received: January 7, 2013
Last updated: September 10, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: March 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)